As a master regulator of the DNL pathway, sterol regulatory element-binding protein 1c (SREBP1c), primarily activated by insulin, exhibited a significant increase in MASLD patients compared to those without MASLD [17,20,22,23,24,25], underscoring its central role in governing this metabolic process. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.